Logo image of IBTA

IBOTTA INC-CL A (IBTA) Stock Fundamental Analysis

NYSE:IBTA - New York Stock Exchange, Inc. - US4510511060 - Common Stock - Currency: USD

65.25  -3.39 (-4.94%)

After market: 65.25 0 (0%)

Fundamental Rating

5

IBTA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 93 industry peers in the Media industry. IBTA has an excellent financial health rating, but there are some minor concerns on its profitability. IBTA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

IBTA had positive earnings in the past year.
IBTA Yearly Net Income VS EBIT VS OCF VS FCFIBTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 20M -20M 40M -40M -60M

1.2 Ratios

The Return On Assets of IBTA (1.87%) is better than 64.37% of its industry peers.
IBTA's Return On Equity of 2.97% is fine compared to the rest of the industry. IBTA outperforms 60.92% of its industry peers.
IBTA's Return On Invested Capital of 9.22% is amongst the best of the industry. IBTA outperforms 85.06% of its industry peers.
Industry RankSector Rank
ROA 1.87%
ROE 2.97%
ROIC 9.22%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBTA Yearly ROA, ROE, ROICIBTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 0 50 -50 100 150

1.3 Margins

With a decent Profit Margin value of 3.04%, IBTA is doing good in the industry, outperforming 62.07% of the companies in the same industry.
IBTA has a better Operating Margin (11.18%) than 68.97% of its industry peers.
IBTA has a Gross Margin of 87.17%. This is amongst the best in the industry. IBTA outperforms 96.55% of its industry peers.
Industry RankSector Rank
OM 11.18%
PM (TTM) 3.04%
GM 87.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IBTA Yearly Profit, Operating, Gross MarginsIBTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 20 -20 40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

IBTA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IBTA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, IBTA has an improved debt to assets ratio.
IBTA Yearly Shares OutstandingIBTA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 10M 20M 30M
IBTA Yearly Total Debt VS Total AssetsIBTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 6.79 indicates that IBTA is not in any danger for bankruptcy at the moment.
IBTA's Altman-Z score of 6.79 is amongst the best of the industry. IBTA outperforms 91.95% of its industry peers.
IBTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.79
ROIC/WACC1.02
WACC9.01%
IBTA Yearly LT Debt VS Equity VS FCFIBTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 2.72 indicates that IBTA has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.72, IBTA belongs to the best of the industry, outperforming 85.06% of the companies in the same industry.
IBTA has a Quick Ratio of 2.72. This indicates that IBTA is financially healthy and has no problem in meeting its short term obligations.
IBTA has a Quick ratio of 2.72. This is amongst the best in the industry. IBTA outperforms 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 2.72
Quick Ratio 2.72
IBTA Yearly Current Assets VS Current LiabilitesIBTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 50M 100M 150M 200M 250M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 169.48% over the past year.
IBTA shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.89%.
EPS 1Y (TTM)169.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)51.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 42.65% on average over the next years. This is a very strong growth
IBTA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.26% yearly.
EPS Next Y-80.58%
EPS Next 2Y46.05%
EPS Next 3Y42.65%
EPS Next 5YN/A
Revenue Next Year18.72%
Revenue Next 2Y17.64%
Revenue Next 3Y18.26%
Revenue Next 5YN/A

3.3 Evolution

IBTA Yearly Revenue VS EstimatesIBTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 100M 200M 300M 400M 500M
IBTA Yearly EPS VS EstimatesIBTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 593.18, which means the current valuation is very expensive for IBTA.
Compared to the rest of the industry, the Price/Earnings ratio of IBTA is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 29.63, IBTA is valued quite expensively.
The Price/Forward Earnings ratio is 24.27, which indicates a rather expensive current valuation of IBTA.
IBTA's Price/Forward Earnings is on the same level as the industry average.
IBTA is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 593.18
Fwd PE 24.27
IBTA Price Earnings VS Forward Price EarningsIBTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IBTA is valued a bit more expensive than the industry average as 71.26% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.79
IBTA Per share dataIBTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as IBTA's earnings are expected to grow with 42.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.05%
EPS Next 3Y42.65%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IBTA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IBOTTA INC-CL A

NYSE:IBTA (2/21/2025, 8:27:16 PM)

After market: 65.25 0 (0%)

65.25

-3.39 (-4.94%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)02-26 2025-02-26/amc
Inst Owners48.36%
Inst Owner Change25.4%
Ins Owners17.92%
Ins Owner Change-0.7%
Market Cap2.00B
Analysts82.67
Price Target85 (30.27%)
Short Float %13.2%
Short Ratio7.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-5.14%
Min EPS beat(2)-52.55%
Max EPS beat(2)42.28%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.67%
Min Revenue beat(2)0.55%
Max Revenue beat(2)2.8%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.09%
PT rev (3m)-13.49%
EPS NQ rev (1m)-5.19%
EPS NQ rev (3m)-32.02%
EPS NY rev (1m)1.69%
EPS NY rev (3m)12.15%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-11.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.55%
Valuation
Industry RankSector Rank
PE 593.18
Fwd PE 24.27
P/S 5.42
P/FCF N/A
P/OCF N/A
P/B 5.29
P/tB 5.29
EV/EBITDA 36.79
EPS(TTM)0.11
EY0.17%
EPS(NY)2.69
Fwd EY4.12%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.03
BVpS12.34
TBVpS12.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.87%
ROE 2.97%
ROCE 10.65%
ROIC 9.22%
ROICexc 78.34%
ROICexgc 78.34%
OM 11.18%
PM (TTM) 3.04%
GM 87.17%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.72
Quick Ratio 2.72
Altman-Z 6.79
F-ScoreN/A
WACC9.01%
ROIC/WACC1.02
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-80.58%
EPS Next 2Y46.05%
EPS Next 3Y42.65%
EPS Next 5YN/A
Revenue 1Y (TTM)51.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year18.72%
Revenue Next 2Y17.64%
Revenue Next 3Y18.26%
Revenue Next 5YN/A
EBIT growth 1Y238.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.92%
EBIT Next 3Y54.77%
EBIT Next 5YN/A
FCF growth 1Y122.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.21%
OCF growth 3YN/A
OCF growth 5YN/A